| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0aaecb2622856f602ec5e64c42bedcb8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
| filingDate |
1999-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3dee749472a89f8335c7ae63a499ac9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09d5a24a5686c01495489bf3ab20b21e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dd8a0534641c133da47c18357353048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eadbadbb211c04fe94225787c2d35f4b |
| publicationDate |
2003-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6627393-B2 |
| titleOfInvention |
Solutions for use as plasma expanders and substitutes |
| abstract |
An artificial plasma-like substance having at least one water soluble polysaccharide oncotic agent selected from the group consisting of high molecular weight hydroxyethyl starch, low molecular weight hydroxyethyl starch, dextran 40 and dextran 70, which is buffered by lactate and has a pre-administration pH of between 4 and 6.5 is disclosed. In one embodiment, the artificial plasma-like solution may have at least two water soluble polysaccharide oncotic agents one of which is eliminated from the circulation slowly and the other of which is eliminated from the circulation quickly. Supplementation of the plasma-like solution with certain ions is described. A system for administration of the plasma-like solution to a subject wherein the system comprises a first and second solution each having particular buffers is described. Methods for the administration of the plasma-like solution are also disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9827265-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010080859-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005255176-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9161949-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8153164-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005255175-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9895395-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7625586-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006121130-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004082022-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7019035-B2 |
| priorityDate |
1993-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |